Pacific Capital Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-36
Closed -$18.7K 346
2024
Q4
$18.7K Sell
36
-3
-8% -$1.65K ﹤0.01% 224
2024
Q3
$24.1K Sell
39
-64
-62% -$37.9K ﹤0.01% 214
2024
Q2
$57K Buy
103
+6
+6% +$3.44K 0.01% 143
2024
Q1
$56.4K Hold
97
0.01% 127
2023
Q4
$51.5K Buy
+97
New +$47K 0.01% 130
2020
Q4
Sell
-97
Closed -$43K 181
2020
Q3
$43K Buy
+97
New +$40.1K 0.03% 111

Other funds holding TMO

Pacific Capital Wealth Advisors's TMO Position: Q1 2025 in Review

Pacific Capital Wealth Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 36 shares — an estimated $18.7K sold.

Pacific Capital Wealth Advisors first reported a position in TMO in Q3 2020 and held it in 6 quarters. The position peaked at $57K in Q2 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Pacific Capital Wealth Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Pacific Capital Wealth Advisors sold 36 Thermo Fisher Scientific shares in Q1 2025, an estimated $18.7K.
  • Pacific Capital Wealth Advisors first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 6 quarters.
  • Pacific Capital Wealth Advisors's Thermo Fisher Scientific position peaked at $57K in Q2 2024.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Pacific Capital Wealth Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.